Ledger.Open graph →
SEC Form D · filed January 7, 2021

Octave Bioscience Inc

Offering
$32.0M
Sold
$32.0M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
MENLO PARK, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Thomas Hawes · MENLO PARK, CADirectorBrook Byers · MENLO PARK, CADirectorMelinda Thomas · MENLO PARK, CAExecWilliam Hagstrom · MENLO PARK, CAExec · DirectorMichael Pellini · MENLO PARK, CADirectorAndrea Jackson · MENLO PARK, CADirectorGeorge Scangos · MENLO PARK, CADirectorA. Grant Heidrich Iii · MENLO PARK, CADirectorKenton C. Leo · Lone Tree, COExec · DirectorAngela J. Brau · Provo, UTDirectorClifford Pollard · Oakdale, CADirectorJonathan D. Herpy · Wilmington, DEDirectorJonathan Landsverk · Greenville, SCDirectorChristopher Mclaughlin · Chicago, ILExecDana Emberton · Greenville, SCDirectorDerrin J. Hill · Provo, UTDirectorMark Weeks · Palo Alto, CAExecBobby Marhamat · San Francisco, CAExec · DirectorJack Abraham · San Francisco, CAExecTuan Ho · San Francisco, CADirectorLeo Polovets · San Francisco, CADirectorChad Byers · San Francisco, CADirectorBrandon Tseng · San Diego, CADirectorDaniel Gwak · San Diego, CADirectorPeter Levine · San Diego, CADirectorMark Weeks · Palo Alto, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗